Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AVASTIN Latest News

DEC 11, 2013 - MedPage Today

A Must Read - Share

Avastin Misses Mark Again in Breast Cancer (CME/CE)

SAN ANTONIO (MedPage Today) -- The addition of bevacizumab (Avastin) to standard adjuvant therapy for HER2-positive breast cancer failed to improve invasive disease-free survival in a randomized clinical trial.

Tags: Avastin Misses Mark Again in Breast Cancer (CME/CE),  Avastin Latest News